To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy

Journal of Affective Disorders

Volumn 48, Issue 2-3, 1998, Pages 215-225

  Blumer, Dietrich ^a   Herzog, Andrew G ^b   Himmelhoch, Jonathan ^c   Salgueiro, Carlos A ^a   Ling, Frank W ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d University of Tennessee Extension   (United States)

Author keywords

Interictal dysphoric disorder; Premenstrual dysphoric disorder; Treatment for affective disorder of epilepsy; Treatment for premenstrual dysphoria

Indexed keywords

ADULT; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DYSPHORIA; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMAN; IRRITABILITY; MENSTRUAL CYCLE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; IRRITABLE MOOD; PREMENSTRUAL SYNDROME; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; VALPROIC ACID;

EID: 0031800876     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00173-0     Document Type: Article

References (33)

1. Akiskal, H.S., 1994. Mood disturbances. In: Winokur G., Clayton P.J. (Eds.), The medical basis of psychiatry, 2nd ed. Saunders, Philadelphia, pp. 365-379.
2. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54:1976;321-347.
3. Bleuler, E., 1949. Lehrbuch der Psychiatrie, 8th ed. by Bleuler, Springer, Berlin.
4. Blumer, D., 1984. The psychiatric dimension of epilepsy: historical perspective and current significance. In: Blumer, D. (Ed.), Psychiatric aspects of epilepsy. APA Press, Washington, DC, pp. 26-37.
5. Blumer, D., 1994. Psychiatric evaluation of patients with unilateral temporal lobectomy for epilepsy. In: Wyler, A., Hermann, B. (Eds.), The surgical treatment of epilepsy. Butterworth-Heineman, London, pp. 90-96.
6. Blumer D. Antidepressant and double-antidepressant treatment for the affective disorder of epilepsy. J. Clin. Psychiatry. 58:1997;3-11.
7. Blumer D., Heilbronn M., Himmelhoch J. Indications for carbamazepine in mental illness: atypical psychiatric disorder or temporal lobe syndrome? Comprehen. Psyc. 29(2):1988;108-122.
8. Blumer D., Zielinski J.J. Pharmacologic treatment of psychiatric disorders associated with epilepsy. J. Epilepsy. 1:1988;135-150.
9. Blumer, D., Altshuler, L., 1997. Affective disorders associated with epilepsy. In: Engel J., Pedley, T. (Eds.), Epilepsy. A Comprehensive Textbook. Raven Press, New York, in press.
10. Blumer D., Montouris G., Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J. Neuropsychiatry Clin. Neurosci. 7:1995;445-456.
11. Blumer, D., Wakhlu, S., Davies, K., Hermann, B. Psychiatric outcome of temporal lobectomy for epilepsy, submitted for publication.
12. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV) (1994). American Psychiatric Press, Washington, DC, pp. 715-718.
13. Eriksson E., Hedberg M.A., Andersch B., Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 12(2):1995;169-176.
14. Freeman E., Rickels K., Sondheimer S.J.et al. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. J. Am. Med. Assoc. 264(3):1990;349-353.
15. Gangdev P.S., Joshi V.S., Karnik P.R.et al. Efficacy of carbamazepine in premenstrual syndromes. A report on four cases. J. Assoc. Physicians, India. 39(5):1991;419-420.
16. Gastaut, H., Morin. G., Lesèvre, N., 1955, Étude du comportement des épileptiques psychomoteurs dans l'intervalle de leurs crises: les troubles de l'activité globale et de la sociabilité, Ann. Med. Psychol. (Paris), 113, 1-27.
17. Goldstein, S., Halbreich, U., 1993. Psychotropic medications as treatment of dysphoric premenstrual syndrome. In: Smith, S., Schiff, I. (Eds.), Modern management of premenstrual syndrome. Norton, New York, pp. 120-127.
18. Herzog A.G. Perimenopausal depression: possible role of anomalous brain substrates. Brain Dysfunction. 2:1989;146-154.
19. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurol. 45:1995;1660-1662.
20. Herzog A.G., Klein P., Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia. 38(10):1997;1082-1088.
21. Himmelhoch, J., 1984. Major mood disorders related to epilepsy. In: Blumer D. (Ed.), Psychiatric Aspects of Epilepsy. American Psychiatric Press, Washington, DC, pp. 271-294.
22. Howard R., Mason P., Taghavi E.et al. Brainstem auditory evoked responses (BAERs) during the menstrual cycle in women with and without premenstrual syndrome. Biol Psychiatry. 32:1992;682-690.
23. Isaacson, K., Balasubramanyam, A., 1993. Relationship of medical illness to the menstrual cycle. In: Smith, S., Schiff, I. (Eds.), Modern Management of Premenstrual Syndrome. Norton, New York, pp. 82-97.
24. Jacobsen F.M. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J. Clin. Psychiatry. 54:1993;229-234.
25. Janz, D., 1969. Die Epilepsien. Thieme, Stuttgart, p. 240.
26. Kraepelin E., 1923. Psychiatrie. 8th ed. Barth, Leipzig.
27. Leary P.M., Batho K. Changes in the electroencephalogram related to the menstrual cycle. SAfr. Med. J. 55:1979;666-668.
28. Morel, B.A., 1860. D'une forme de délire, suite d'une surexcitation nerveuse se rattachant a une variété non encore décrite d'épilepsie: l'épilepsie larvée. Gazette hebdomadaire de médecine et de chirurgie 7, 773-775, 819-821, 836-841.
29. Rivera-Tovar, A., Rhodes, R., Pearlstein, T.B., et al., 1994. Treatment Efficacy. In: Gold, J.H., Severino, S.K. (Eds.), Premenstrual dysphorias. American Psychiatric Press, Washington, DC, pp. 99-148.
30. Severino S.K., Yonkers K.A. A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics. 4:1993;299-306.
31. Steiner M., Steinberg S., Stewart D., Carter D.et al. Fluoxetine in the treatment of premenstrual dysphoria. N. Engl. J. Med. 332(23):1995;1529-1534.
32. Szondi, L., 1963. Schicksalsanalytische Therapie. Hans Huber, Bern.
33. Yonkers K.A., Halbreich U., Freeman E.et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. J. Am. Med. Assoc. 278:1997;983-988.